Chinese guidelines on management of hepatic encephalopathy in cirrhosis

Table 1 Evidence level and recommendation strength

Level	Detailed description
Evidence Level
A	High quality: Further research cannot change the reliability of these treatment assessment results.
B	Moderate quality: Further research may influence the reliability of these treatment assessment results, and may change the treatment assessment results.
C	Low or very low quality: Further research will very likely influence the reliability of these treatment assessment results, and will very likely change the treatment assessment results.
Recommendation strength
1	Strong recommendation: It is clearly shown that either the benefits of intervention clearly outweigh the disadvantages, or that the disadvantages outweigh the benefits.
2	Weak recommendation: The benefits and disadvantages are unclear, or, regardless of the quality of the evidence, the benefits and disadvantages are comparable.